Literature DB >> 1526784

Gross composition and plasma and extracellular water volumes of tissues of a reference mouse.

P W Durbin1, N Jeung, B Kullgren, G K Clemons.   

Abstract

The laboratory mouse is a primary animal model for experimental radiation biology and pharmacology. The usefulness of the mouse for those purposes is enhanced if detailed data are available to define a Reference Mouse [weight and composition of soft tissues and bones and their in-life content of plasma and extracellular water (ECW)]. Only fragmentary data are available for wet weights and plasma volumes of soft tissues and bones of mice; there are no reports of total volume or distribution of ECW in mouse tissues. To remedy those defects, wet weight and composition of all major organs and soft tissues were measured, and measurements were made or estimates obtained for wet weights and composition of all bones of the young adult (12 to 13 wk old) female Swiss-Webster mouse. 125I-transferrin was used as a tracer for plasma, and 22Na was used as a tracer for ECW. Tissue weight and tracer measurements were conducted using the metabolic balance approach and a freezing technique that avoids blood loss during dissection. Results compare favorably with published weights and plasma volumes of tissues of mature mice of both genders and other strains. Total plasma volume (48.9 +/- 4.4 microL g-1) and Na-space (232 +/- 15 microL g-1), and the specific plasma and ECW volumes of vascular mouse tissues, exceed those of rat tissues. Applications of the data are presented: (1) interpretation of plutonium uptake kinetics in the mouse; (2) estimation of masses of mineralized bone tissue (1.92 g), bone marrow (1.2 g), and endosteal (BS) cells (0.2 g) of the mouse.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1526784     DOI: 10.1097/00004032-199210000-00007

Source DB:  PubMed          Journal:  Health Phys        ISSN: 0017-9078            Impact factor:   1.316


  7 in total

Review 1.  Quantification and three-dimensional microanatomical organization of the bone marrow.

Authors:  Cesar Nombela-Arrieta; Markus G Manz
Journal:  Blood Adv       Date:  2017-02-14

2.  Evaluation of the pharmacokinetic drug-drug interaction potential of iohexol, a renal filtration marker.

Authors:  Anand Joshi; Jianxia Guo; Julianne L Holleran; Brian Kiesel; Sarah Taylor; Susan Christner; Robert A Parise; Brian M Miller; S Percy Ivy; Edward Chu; Raman Venkataramanan; Jan H Beumer
Journal:  Cancer Chemother Pharmacol       Date:  2020-09-18       Impact factor: 3.333

3.  From early prophylaxis to delayed treatment: Establishing the plutonium decorporation activity window of hydroxypyridinonate chelating agents.

Authors:  Dahlia D An; Birgitta Kullgren; Erin E Jarvis; Rebecca J Abergel
Journal:  Chem Biol Interact       Date:  2016-03-31       Impact factor: 5.192

4.  Lack of cell-cycle-specific effects of recombinant tumor necrosis factor in vivo.

Authors:  M Jäckel; P Köpf-Maier; R Tausch-Treml
Journal:  Cancer Immunol Immunother       Date:  1994-11       Impact factor: 6.968

5.  Dosimetric evaluation and radioimmunotherapy of anti-tumour multivalent Fab' fragments.

Authors:  J L Casey; R B Pedley; D J King; A J Green; G T Yarranton; R H Begent
Journal:  Br J Cancer       Date:  1999-11       Impact factor: 7.640

6.  Evaluating the potential of chelation therapy to prevent and treat gadolinium deposition from MRI contrast agents.

Authors:  Julian A Rees; Gauthier J-P Deblonde; Dahlia D An; Camille Ansoborlo; Stacey S Gauny; Rebecca J Abergel
Journal:  Sci Rep       Date:  2018-03-13       Impact factor: 4.379

Review 7.  Utility of Intravenous Curcumin Nanodelivery Systems for Improving In Vivo Pharmacokinetics and Anticancer Pharmacodynamics.

Authors:  Mahsa Bagheri; Cornelus F van Nostrum; Robbert Jan Kok; Gert Storm; Wim E Hennink; Michal Heger
Journal:  Mol Pharm       Date:  2022-08-16       Impact factor: 5.364

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.